The maker of Wegovy and Ozempic generated $2.4bn in sales from weight-loss treatments last year

Obesity drugs: broadly good for investors, with some strictures


Obesity drugs are generating a buzz to rival chatbots and quantum computers. Wegovy, an injectable drug, Ozempic and several other diabetic treatments have gone viral on social media. Elon Musk and Hollywood celebrities say they have used the drugs to shed weight.
One side effect of the treatments, which use a hormone to regulate appetite, should be scepticism. Wonder drugs, from Valium to Zantac, have a history of unintended consequences. But at least one slimming institution is giving obesity treatments an apparent vote of confidence: WeightWatchers.

This story originally appeared on: Financial Times - Author:Faqs of Insurances